Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Odiparcil in non-valvular atrial fibrillation
NCT00240643Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2005
- Primary completion
- Dec 2006
- Countries
- 25
01
Overview
A Phase 2 trial of odiparcil in Atrial fibrillation (AFib), sponsored by GSK. Started Nov 2005; status: completed.
02
Drugs
odiparcil
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00240643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00240643.